60
Participants
Start Date
May 31, 2012
Primary Completion Date
January 31, 2013
Study Completion Date
February 28, 2013
empegfilrastim
Empegfilgrastim is supplied as solution for injection 3 mg/ml. Empegfilgrastim is to be administered 24 h after the chemotherapy at dose of 3 or 6 mg.
filgrastim
Filgrastim should be administered no earlier than 24 hours after the administration of cytotoxic chemotherapy. Filgrastim should be administered daily for up to 2 weeks until the ANC has reached 10 000/mm3 following the expected chemotherapy-induced neutrophil nadir.
Arkhangelsk District Clinical Oncology Dispensary, Arkhangelsk
N.N.Petrov Oncology Research Center, Saint Petersburg
Volgograd District Oncology Dispensary №1, Volgograd
Perm Region Oncology Dispensary, Perm
Russian scientific center of radiology and surgery technologies, Saint Petersburg
Lead Sponsor
Biocad
INDUSTRY